Development of hyperdiploidy starts at an early age and takes a decade to complete.

IF 21 1区 医学 Q1 HEMATOLOGY Blood Pub Date : 2024-11-21 DOI:10.1182/blood.2024025250
Mehmet K Samur, Anil Aktas Samur, Parth Shah, Joseph Park, Mariateresa Fulciniti, Masood A Shammas, Jill Corre, Kenneth C Anderson, Giovanni Parmigiani, Hervé Avet-Loiseau, Nikhil C Munshi
{"title":"Development of hyperdiploidy starts at an early age and takes a decade to complete.","authors":"Mehmet K Samur, Anil Aktas Samur, Parth Shah, Joseph Park, Mariateresa Fulciniti, Masood A Shammas, Jill Corre, Kenneth C Anderson, Giovanni Parmigiani, Hervé Avet-Loiseau, Nikhil C Munshi","doi":"10.1182/blood.2024025250","DOIUrl":null,"url":null,"abstract":"<p><p>Nearly half of multiple myeloma (MM) patients have hyperdiploidy (HMM) at diagnosis. Although HMM occurs early, the mutational processes before and after hyperdiploidy are still unclear. Here, we used 72 WGS samples from patients with HMM and identified pre and post HMM mutation to define the chronology of development of hyperdipoidy. A MM cell accumulated on median 0.56 mutations per mb pre-HMM and for every clonal pre-HMM mutation, 1.21 mutations accumulated post-HMM. This analysis using mutations before and after hyperdiploidy show that hyperdiploidy happens after somatic hypermutation, pre-hyperdipoidy muations are AID and age/Clock-like signature driven whereas post-hyperdiploidy mutations are from DNA damage and APOBEC. Interestingly, the first hyperdiploidy event occured within the first 3 decades of life and took a decade to complete. Copy number changes affecting chromosomes 15 and 19 occurred first. Finally, mutations pre initiating event affected chromosomes at different rates while post-initiating event mutational processes affect each chromosomes equally.</p>","PeriodicalId":9102,"journal":{"name":"Blood","volume":" ","pages":""},"PeriodicalIF":21.0000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/blood.2024025250","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Nearly half of multiple myeloma (MM) patients have hyperdiploidy (HMM) at diagnosis. Although HMM occurs early, the mutational processes before and after hyperdiploidy are still unclear. Here, we used 72 WGS samples from patients with HMM and identified pre and post HMM mutation to define the chronology of development of hyperdipoidy. A MM cell accumulated on median 0.56 mutations per mb pre-HMM and for every clonal pre-HMM mutation, 1.21 mutations accumulated post-HMM. This analysis using mutations before and after hyperdiploidy show that hyperdiploidy happens after somatic hypermutation, pre-hyperdipoidy muations are AID and age/Clock-like signature driven whereas post-hyperdiploidy mutations are from DNA damage and APOBEC. Interestingly, the first hyperdiploidy event occured within the first 3 decades of life and took a decade to complete. Copy number changes affecting chromosomes 15 and 19 occurred first. Finally, mutations pre initiating event affected chromosomes at different rates while post-initiating event mutational processes affect each chromosomes equally.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
超二倍体的发育始于幼年,需要十年才能完成。
近一半的多发性骨髓瘤(MM)患者在确诊时存在超二倍体(HMM)。虽然HMM发生得很早,但其前后的突变过程仍不清楚。在这里,我们使用了 72 份来自 HMM 患者的 WGS 样本,并确定了 HMM 前后的突变,从而确定了超倍性发展的时间顺序。一个 MM 细胞在 HMM 前每 mb 中位积累了 0.56 个突变,而 HMM 前的每一个克隆突变在 HMM 后积累了 1.21 个突变。利用超二倍体前后的突变进行的分析表明,超二倍体发生在体细胞超突变之后,超二倍体前的突变是由AID和年龄/Clock样特征驱动的,而超二倍体后的突变则来自DNA损伤和APOBEC。有趣的是,第一个超倍性事件发生在人出生后的头 30 年,历时 10 年才完成。影响 15 号和 19 号染色体的拷贝数变化最先发生。最后,启动事件前的突变对染色体的影响率不同,而启动事件后的突变过程对每条染色体的影响率相同。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Blood
Blood 医学-血液学
CiteScore
23.60
自引率
3.90%
发文量
955
审稿时长
1 months
期刊介绍: Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate.
期刊最新文献
Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19. The Contribution of the Monocyte-Macrophage Lineage to Immunotherapy Outcomes. Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma. Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation. Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1